logo
Wexford woman hits the streets for mini marathon to mark milestone birthday of child that keeps defying the odds

Wexford woman hits the streets for mini marathon to mark milestone birthday of child that keeps defying the odds

On Sunday, June 1, Sarah Dowling, Niamh Davis and Sinéad Burns will lace up their runners and hit the streets of Dublin for the VHI Women's Mini Marathon, running 10km in support of a special little boy and the charity that's helped his family every step of the way.
Speaking ahead of the mini marathon, Niamh said, 'We are so proud of Eilish and her family and really want to push ourselves to give back to Jack and Jill. Matthew has continued to defy the odds and given the nature of his condition we know how important it is to the Begley's to celebrate his birthday every month. So, as he approaches his 24 month birthday we would love to mark that milestone by reaching a fundraising target of €2,400.'
Matthew Begley, aged 22 months, lives in Gorey with his mum Eilish, dad John, and big brother Patrick. Born with a rare and complex heart condition, Matthew has no pulmonary artery and lives with a life-limiting diagnosis.
Against all odds, he continues to amaze everyone with his strength, love of the outdoors, and beautiful smile. Since his birth the Jack and Jill Children's Foundation has provided vital in-home nursing support to Matthew.
Sarah, a nurse from Waterford and a long-time friend of Eilish, has seen first-hand just how much the Jack and Jill Foundation means to the Begley family. Wanting to do something meaningful, she rallied her friends Niamh and Sinéad who are also friends with Eilish to join her in running the mini marathon.
Matthew's mum Eilish will also take part in the mini marathon this year alongside her friends, in solidarity for the support her family has received. 'Every moment with Matthew is precious. Jack and Jill give us the gift of time at home together. Taking part in this run is my way of saying thank you—and celebrating how far we've come.'
The Jack and Jill Children's Foundation stepped in when Matthew was just ten days old, making it possible for him to come home from hospital and spend time with his family. Since then, their dedicated nursing support has allowed Eilish and John to care for Matthew at home while also meeting the needs of big brother Patrick.
Running the VHI Women's Mini Marathon is more than a fitness goal for this group, it's a show of friendship, support and community spirit. They're running for Matthew, for Eilish and over 430 families just like the Begleys across Ireland who are supported by the Jack and Jill Foundation.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'Hope on horizon' as new drugs tested for Alzheimer's treatment
'Hope on horizon' as new drugs tested for Alzheimer's treatment

RTÉ News​

time3 days ago

  • RTÉ News​

'Hope on horizon' as new drugs tested for Alzheimer's treatment

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer's disease. Some 138 new treatments are being assessed for the treatment and prevention of Alzheimer's. A third of drugs currently being trialled are "repurposed" medications that are already being used to tackle other diseases, including diabetes, multiple sclerosis and cholesterol, according to the new review. One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drug Ozempic and weight loss drug Wegovy, can slow the progression of dementia. And four late-stage trials are looking at preventing disease. Experts said that drugs targeting amyloid protein build up in the brain, such as lecanemab and donanemab, are "only one part of the overall strategy" as they expressed excitement over the variety of new drugs, which are being tested among patients. The new review of Alzheimer's disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs. The number of trials represents an 11% increase on the previous year, according to the review, which was led by an expert from the University of Nevada in the US and has been published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions. Commenting on the paper, Dr Sheona Scales, director of research at Alzheimer's Research UK, said: "This year has really given us real cause for optimism." She said that as well as more drugs coming through the pipeline, the treatment targets are "more diverse" and "looking at all stages of the disease". She added: "What this paper is showing us is that the pipeline of drug development is growing, it's diversifying and accelerating." "This latest report shows us that there is hope on the horizon for people with Alzheimer's, building on lecanemab and donanemab." Dr Emma Mead, chief scientific officer of the Oxford Drug Discovery Institute, added: "Today we are at a tipping point in dementia research as we understand more and more about the diseases that drive dementia. "This gives us opportunities to slow and ultimately stop this devastating condition and today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments." James Rowe, professor of cognitive neurology at the University of Cambridge and consultant neurologist, said: "What strikes me is not just the number of new drugs, which is increasing year on year, but their range of targets (and) the range in which they work, giving us multiple shots on goal." On the drugs which are being investigated for the prevention of disease, Prof Rowe said: "One of the most exciting things of this report is the number of large-scale late-stage trials on prevention. "And the aspiration to prevent, not just treat, is starting to be seen in the figures we see in these charts today." He added: "One way this can work is you take a treatment that you show to be working in people with symptoms with the illness, and then you simply bring it forward by some years. "The ones that are in trial at the moment are really... bringing forward an effective treatment to earlier stage." For instance, people with a genetic risk of Alzheimer's could receive some drugs earlier to see if they protect against the disease. On the repurposing of current drugs, Dr Mead said that it can usually take ten to 15 years for new drugs to be tested and approved for use. "Being able to repurpose drugs licensed for other health conditions could help to accelerate progress and help to open up other avenues to prevent or treat dementia causing diseases," she said. "A really promising example of this is the drug semaglutide, which is currently being trialled in people with mild cognitive impairment." Meanwhile, academics said lecanemab and donanemab, which can be used for treating mild cognitive impairment in Alzheimer's patients, are an "important first step" in the battle against the disease. The treatments were initially approved for UK use by regulators but then deemed not cost-effective for NHS use. The National Institute for Health and Care Excellence (NICE) is taking more evidence on donanemab and lecanemab and is expected to announce its decision in the summer. Dr Scales added: "Lecanemab and donanemab have represented a huge leap forward in our understanding and ability to be able to treat Alzheimer's disease. "What they've done is they've proved that we're able to modify the course of Alzheimer's disease, and what that has done is opened up the door to future treatments that we hope are more effective, easier to deliver and able to deliver for our patients." She said studies are showing "even more complexities" around Alzheimer's and that in the future, people may be treated with a combination of drugs, depending on when they are diagnosed and the type of dementia they have.

Wexford woman hits the streets for mini marathon to mark milestone birthday of child that keeps defying the odds
Wexford woman hits the streets for mini marathon to mark milestone birthday of child that keeps defying the odds

Irish Independent

time30-05-2025

  • Irish Independent

Wexford woman hits the streets for mini marathon to mark milestone birthday of child that keeps defying the odds

On Sunday, June 1, Sarah Dowling, Niamh Davis and Sinéad Burns will lace up their runners and hit the streets of Dublin for the VHI Women's Mini Marathon, running 10km in support of a special little boy and the charity that's helped his family every step of the way. Speaking ahead of the mini marathon, Niamh said, 'We are so proud of Eilish and her family and really want to push ourselves to give back to Jack and Jill. Matthew has continued to defy the odds and given the nature of his condition we know how important it is to the Begley's to celebrate his birthday every month. So, as he approaches his 24 month birthday we would love to mark that milestone by reaching a fundraising target of €2,400.' Matthew Begley, aged 22 months, lives in Gorey with his mum Eilish, dad John, and big brother Patrick. Born with a rare and complex heart condition, Matthew has no pulmonary artery and lives with a life-limiting diagnosis. Against all odds, he continues to amaze everyone with his strength, love of the outdoors, and beautiful smile. Since his birth the Jack and Jill Children's Foundation has provided vital in-home nursing support to Matthew. Sarah, a nurse from Waterford and a long-time friend of Eilish, has seen first-hand just how much the Jack and Jill Foundation means to the Begley family. Wanting to do something meaningful, she rallied her friends Niamh and Sinéad who are also friends with Eilish to join her in running the mini marathon. Matthew's mum Eilish will also take part in the mini marathon this year alongside her friends, in solidarity for the support her family has received. 'Every moment with Matthew is precious. Jack and Jill give us the gift of time at home together. Taking part in this run is my way of saying thank you—and celebrating how far we've come.' The Jack and Jill Children's Foundation stepped in when Matthew was just ten days old, making it possible for him to come home from hospital and spend time with his family. Since then, their dedicated nursing support has allowed Eilish and John to care for Matthew at home while also meeting the needs of big brother Patrick. Running the VHI Women's Mini Marathon is more than a fitness goal for this group, it's a show of friendship, support and community spirit. They're running for Matthew, for Eilish and over 430 families just like the Begleys across Ireland who are supported by the Jack and Jill Foundation.

Transplant patient's plan for mortgage, marathon, marriage and Master's after op
Transplant patient's plan for mortgage, marathon, marriage and Master's after op

Irish Daily Mirror

time28-05-2025

  • Irish Daily Mirror

Transplant patient's plan for mortgage, marathon, marriage and Master's after op

A woman who has had two kidney transplants after a lifetime of ill-health is now set for this weekend's mini marathon in Dublin. Jessie Doyle, 29, is not only in training for the big run on Sunday – she has also bought a house, is planning her marriage and finishing her university Master's degree. Jessie has revealed her mortgage, marathon, marriage and Master's schedule to highlight the crucial work of the Irish Kidney Association (IKA). She said: 'It's a full-circle moment. For so long, I couldn't plan for the future. Now I'm doing it all at once by running, graduating and getting married. I spent years being sick, staring out the hospital window, wishing I could just be outside walking. Now, I have that freedom, and I want to use it.' This June Bank Holiday Weekend, Jessie, who is from Westmeath but now lives in Santry, Co Dublin, takes on the Vhi Women's Mini Marathon for the very first time. A spokesperson for the IKA said Jessie's story is a 'powerful symbol of resilience and gratitude' that was made 'possible by her donors' and two kidney transplants. Despite years of illness and fatigue and unexplained symptoms, it was not until Jessie was 17 years old that she was diagnosed with chronic kidney disease. The Midland Regional Hospital in Tullamore in Offaly confirmed the chronic kidney disease and revealed that her kidney function had dropped to 30 per cent. The next 12 years were filled with illness, dialysis treatment, her first kidney transplant at age 20 in 2016 and her second at age 27 in 2023. Jessie said: 'In school, I was often seen as an anxious child who was always unwell. It wasn't until I went to the doctor with abdominal pain that they discovered high protein levels in my urine which pointed towards kidney problems. I was still in school, doing my Leaving Cert. It was a really tough time. It was very isolating. I missed months of school, couldn't go out with friends, and often felt like nobody understood what I was going through. 'For my 18th birthday celebration, I had one drink and went home to bed as I was feeling exhausted. I started dialysis after completing my Leaving Cert and by then my kidney function had fallen to 12 per cent.' Hospital dialysis meant Jessie delayed university and registered to go on the kidney transplant waiting list. After her first transplant, Jessie said it took 'three weeks for the donor kidney to begin working properly and I gradually began to feel energised'. She added: 'I felt like a different person.' After putting her life on hold for dialysis, Jessie was finally able to go to university to study Multimedia at Dublin City University (DCU). She also completed a Master's degree in Climate Change, Policy and Media – but her kidney function began to deteriorate in 2021. Jessie said: 'It was devastating to be back on dialysis. My renal consultant told me I could be waiting for up to four years for another transplant. 'It was a huge blow. I had only been on dialysis for four weeks. Then, that same evening, I received the call, there was a perfect match for me. I couldn't believe it, that my wait on the transplant list was so short.' Jessie's second transplant was successful. Unlike the first, the kidney began functioning immediately and she was discharged from hospital in just five days. She is now planning her future with her fiancé Aaron Hoey and the couple have just bought a house and are preparing for their wedding on September 6. A few weeks later, Jessie will graduate with her second Master's degree, this one in Visual Communications from TU Dublin. A spokesperson for the IKA said: 'Taking part in the VHI Mini Marathon is a powerful symbol of everything Jessie has fought to overcome. With her health restored, she is not only stepping up to the start line in Dublin city centre, she's also planning for two big events this September - her wedding in Kilkenny and to graduate with her second Master's from college.' There are over 2,500 people in Ireland receiving dialysis treatment and over 500 of them are on a waiting list for a kidney transplant. More information on the Irish Kidney Association is available on its website. Jessie told potential donors: 'You don't just give someone an organ, you give them their life back. I wouldn't be here without my donors. It's the most selfless act imaginable. I remain eternally grateful to my donors' families.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store